Clinical Trial Update: Allogeneic BM-MSC's in Patients With Lumbar Facet Arthropathy [Phase 2]

View source ↗

Summary

Phase 2 trial of allogeneic bone marrow-derived mesenchymal stem cells for lumbar facet arthropathy (facet-mediated low back pain); status is active but not rec…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Facet-mediated Low Back Pain

Drugs mentioned

• Allogeneic BM-MSCs (bone marrow-derived mesenchymal stem cells)

Snippet

Sponsor: Mayo Clinic | Conditions: Facet-Mediated Low Back Pain | Phase 2 | Status: ACTIVE_NOT_RECRUITING